Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2008
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
12/31/2008EP2007734A1 Enzyme inhibitors
12/31/2008EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
12/31/2008EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase
12/31/2008EP1737863B1 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
12/31/2008EP1727812B1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/31/2008EP1680415B1 Pyrrolidinyl urea derivatives as angiogenesis inhibitors
12/31/2008EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
12/31/2008EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
12/31/2008EP1276741B1 Phenyl substituted 4-hydroxy tetrahydropyridone and its use as pesticide and herbicide
12/31/2008EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound
12/31/2008CN101333216A Novel saltforming process of eprosartan mesylate
12/31/2008CN101333192A Biaryl substituted pyrazoles as sodium channel blockers
12/31/2008CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
12/31/2008CA2691932A1 Use of compounds for preparing anti-tuberculosis agents
12/31/2008CA2690378A1 Phthalazine compounds, compositions and methods of use
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/31/2008CA2690176A1 Novel herbicides
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470798 7,8-bicycloalkyl-chroman derivatives
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008US7470712 Amino-benzazoles as P2Y1 receptor inhibitors
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470709 Benzimidazole quinolinones and uses thereof
12/30/2008US7470702 Benzimidazoles
12/30/2008US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/30/2008US7470689 6-chloro-4-(3H-imidazo[4,5-c]pyridin-2-yl)-2H-pyridazin-3-one and and 4-(3H-imidazol [4,5-c]pyridin-2-yl)-6-pyridin-4-yl-2H-pyridazin-3-one; cyclin-dependent kinase inhibitor; anticarcinogenic, antitumor agent
12/30/2008US7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
12/30/2008CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis
12/30/2008CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/25/2008US20080319047 Novel Glucitol Derivative, Prodrug Thereof And Salt Thereof, And Therapeutic Agent Containing The Same For Diabetes
12/25/2008US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds
12/25/2008US20080319011 Protein tyrosine kinase enzyme inhibitors
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318945 Novel Compounds
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318903 Methods for treating cancer
12/25/2008US20080318902 Triheterocyclic compounds and compositions thereof
12/25/2008US20080317671 Non-imidazole heterocyclic compounds
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156105A1 Organic electroluminescence element material, organic electroluminescence element, display device and illuminating device
12/24/2008WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008WO2008155588A1 Sulfonyl-quinoline derivatives
12/24/2008WO2008155081A2 Substituted aromatic heterocyclic compounds as fungicides
12/24/2008WO2008155034A1 Substituted oxazolidinones and the use thereof
12/24/2008WO2008121861A3 Pyrazole and pyrrole compounds useful in treating iron disorders
12/24/2008WO2008104597A3 Sulfonyltryptophanols
12/24/2008WO2008086226A3 Factor xa inhibitors
12/24/2008WO2008057856A3 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
12/24/2008WO2008009077A3 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
12/24/2008EP2005959A1 External pharmaceutical composition
12/24/2008EP2005958A1 External pharmaceutical composition
12/24/2008EP2004638A1 Anilino-pyrimidine phenyl and benzothiophene analogs
12/24/2008EP2004637A1 Substituted ring fused azines and their use in cancer therapy
12/24/2008EP2004632A1 Hiv inhibiting 5-amido substituted pyrimidines
12/24/2008EP2004623A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
12/24/2008EP2004615A2 Quinazolines for pdk1 inhibition
12/24/2008EP1805169B1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses
12/24/2008EP1554274B1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/24/2008EP1551804B1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
12/24/2008EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
12/24/2008CN101331626A Organic electroluminescence element material and organic electroluminescence element using same
12/24/2008CN101331126A Benzimidazole thiophene compounds as PLK modulators
12/24/2008CN101331124A Novel vanilloid receptor ligands and their use for producing medicaments
12/24/2008CN101331116A N-(6-membered aromatic ring)-amido anti-viral compounds
12/24/2008CN101328163A Compounds, compositions and methods
12/24/2008CN101328135A Carbonyl phenyl propanoic acid derivative compounds
12/24/2008CN100445294C Platinum complex and luminescent element
12/24/2008CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/24/2008CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
12/24/2008CN100445271C Amide derivative
12/24/2008CN100444839C Treatment of chemokine mediated diseases
12/24/2008CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692172A1 Substituted oxazolidinones and the use thereof
12/24/2008CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008CA2690141A1 Inhibitors of janus kinases
12/24/2008CA2690079A1 Sulfonyl-quinoline derivatives
12/24/2008CA2688441A1 Substituted aromatic heterocyclic compounds as fungicides
12/24/2008CA2687255A1 Heteroarylamide pyrimidone derivatives
12/24/2008CA2687151A1 Heteroarylamide pyrimidone compounds
12/23/2008US7468443 central nervous system disorders; regenerating nervous systems
12/23/2008US7468380 Nitrogen-containing aromatic derivatives
12/23/2008US7468373 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/23/2008US7468371 Tricyclic pyrazole kinase inhibitors
12/23/2008US7468369 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
12/23/2008CA2448058C Pyrazole derivatives as hiv reverse transcriptase inhibitors
12/23/2008CA2424664C Novel non-imidazole compounds
12/18/2008WO2008153858A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008WO2008153701A1 Compounds for inhibiting ksp kinesin activity
12/18/2008WO2008153129A1 Agent for lowering uric acid level
12/18/2008WO2008152332A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/18/2008WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008WO2008152159A2 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 523